Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia

American Heart Journal

Volumn 148, Issue 4, 2004, Pages 635-640

  Milionis, Haralampos J ^a   Kakafika, Anna I ^a   Tsouli, Sofia G ^a   Athyros, Vasilios G ^b   Bairaktari, Eleni T ^c   Seferiadis, Konstantinos I ^c   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; STATIN; URIC ACID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINALYSIS;

ANTILIPEMIC AGENTS; FEMALE; HEPTANOIC ACIDS; HOMEOSTASIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; PYRROLES; SIMVASTATIN; URIC ACID;

EID: 5344244028     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.04.005     Document Type: Article

References (27)

1. Bengtsson C., Lapidus L., Stendahl C., et al. Hyperuricemia and risk of cardiovascular disease and overall death a 12-year follow up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand. 224:1988;549-555
2. Brand F.N., McGee D.L., Kannel W.B., et al. Hyperuricemia as a risk factor of coronary heart disease the Framingham Study. Am J Epidemiol. 121:1985;11-18
3. Freedman D.S., Williamson D.F., Gunter E.W., et al. Relation of serum uric acid to mortality and ischemic heart disease the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 141:1995;637-644
4. Liese A.D., Hense H.W., Lowel H., et al. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort World Health Organization monitoring trends and determinants in cardiovascular diseases. Epidemiology. 10:1999;391-397
5. Nieto F.J., Iribaren C., Gross M.D., et al. Uric acid and serum antioxidant capacity a reaction to atherosclerosis? Atherosclerosis. 148:2000;131-139
6. Elisaf M., Tsimichodimos V., Bairaktari E., et al. Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia. J Cardiovasc Pharmacol. 34:1999;60-63
7. Melenovsky V., Malik J., Wichterle D., et al. Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia. Am Heart J. 144:2002;e6
8. Milionis H.J., Elisaf M.S. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia case histories. Curr Med Res Opin. 16:2000;164-170
9. Marais A.D., Firth J.C., Bateman M.E., et al. Atorvastatin an effective lipid modifying agent in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 17:1997;1527-1531
10. Giral P., Bruckert E., Jacob N., et al. Homocysteine and lipid lowering agents a comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia. Atherosclerosis. 154:2001;421-427
11. Kakafika A., Tsimihodimos V., Elisaf M. Effect of atorvastatin on serum uric acid levels. Atherosclerosis. 158:2001;255
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197
14. Maesaka J.K., Fishbane S. Regulation of renal urate excretion a critical review. Am J Kidney Dis. 32:1998;917-933
15. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 21:1998;2191-2192
16. Goudevenos J.A., Bairaktari E.T., Chatzidimou K.G., et al. The effect of atorvastatin on serum lipids, lipoprotein (a) and plasma fibrinogen levels in primary dyslipidaemia a pilot study involving serial sampling. Curr Med Res Opin. 16:2001;269-275
17. Kannel W.B. Metabolic risk factors for coronary heart disease in women perspective from the Framingham Study. Am Heart J. 114:1985;413-419
18. Iribarren C., Sharp D.S., Curb J.D., et al. High uric acid a metabolic marker of coronary heart disease among alcohol abstainers? J Clin Epidemiol. 49:1996;673-678
19. Iribarren C., Folsom A.R., Eckfeldt J.H., et al. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis the ARIC study. Ann Epidemiol. 6:1996;331-340
20. Yano K., Reed D.M., McGee D.L. Ten-year incidence of coronary heart disease in the Honolulu Heart Program relationship to biologic and lifestyle characteristics. Am J Epidemiol. 119:1984;653-656
21. Naknishi N., Suzuki K., Kawashimo H., et al. Serum uric acid correlation with biological, clinical and behavioral factors in Japanese men. J Epidemiol. 9:1999;99-106
22. Longo-Mbenza B., Luila E.L., Mbette P., et al. Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans? Int J Cardiol. 30:1999;17-22
23. Giacomello A., Di Sciascio N., Pio Quaratino C. Relation between serum triglyceride level, serum urate concentration and fractional urate excretion. Metabolism. 46:1997;1085-1089
24. Ginsberg M.H., Kozin F., O'Malley M., et al. Release of platelet constituents by monosodium urate crystals. J Clin Invest. 60:1977;999-1007
25. Sevanian A., Davies K.J., Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr. 54:1991;1129-1134
26. Cappuccio F.P., Strazzullo P., Farinaro E., et al. Uric acid metabolism and tubular sodium handling results from a population-based study. JAMA. 270:1993;354-359
27. Paolisso G., Barbagallo M., Petrella G., et al. Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients. Atherosclerosis. 150:2000;121-127